Risk Factors Associated With Hyperuricemia in Patients with Diabetes Type 2: About 190 Cases
Fennoun H1,2,3, Haraj NE1,2,3, El Aziz S1,2,3, Bensbaa S1,2,3, Chadli A1,2,3
1Endocrinology, Diabetology and Metabolic Diseases Department, Ibn Rochd University Hospital of Casablanca, Morocco
2Laboratory of Neuroscience and Mental Health Clinic, Morocco
3Faculty of Medicine and Pharmacy, University Hassan II, Casablanca, Morocco
Corresponding Author: Asma Chadli
Address: Endocrinology, Diabetology, and Metabolic Diseases Department, Ibn Rochd University Hospital of Casablanca, Morocco; Tel: +212 6 61092820; E-mail: firstname.lastname@example.org
Received date: 08 April 2020; Accepted date: 25 April 2020; Published date: 04 May 2020
Citation: Fennoun H, Haraj NE, El Aziz S, Bensbaa S, Chadli A. Risk Factors Associated With Hyperuricemia in Patients with Diabetes Type 2: About 190 Cases. Diab Res Open Access. 2020 May 4;2(1):12-16.
Copyright © 2020 Fennoun H, Haraj NE, El Aziz S, Bensbaa S, Chadli A. This is an open-access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Keywords: Hyperuricemia, Metabolic Syndrome, Type 2 Diabetes, Uric Acid
Introduction: Hyperuricemia is common Type 2 diabetes at very high cardiovascular risk.
Objective: Evaluate the relationship between hyperuricemia and diabetes type 2, and determine its predictive factors in this population.
Patients and Methods: Retrospective study cross including 190 patients with diabetes type 2 hospitalized Service of Endocrinology of CHU Ibn Rushd Casablanca from January 2015 to December 2017. Hyperuricemia was defined as a serum uric acid concentration> 70 mg/L (men) and> 60 mg/L (women). The variables studied were the anthropometric measurements), cardiovascular factors (tobacco, hypertension, dyslipidemia), and degenerative complications (retinopathy, neuropathy, kidney failure, ischemic heart disease). The analyzes were performed by SPSS software.
Results: Hyperuricemia was found in 26.5% of patients with a female predominance (76%), an average age of 55.9 years, and an average age of 12.4ans diabetes. The glycemic control was found in 84.6% of cases with mean glycated hemoglobin 8.6%.
Factors associated al hyperuricemia were the blood pressure in 86% (p <0.05), dyslipidemia in 76.3% of cases (p <0.001) with hypertriglyceridemia in 48.3% of cases (p <0.02), and a hypoHDLémie 28% (p <0.001). The age, obesity, smoking, and glycemic control were associated significantly n al hyperuricemia.
The research of degenerative complications of hyperuricemia has objectified renal impairment (GFR between 15 and 60ml / min) chez47% (p <0.001), it was kind of moderate in 35.8% (p <0.01) and severe in 5.1% (p <0.02), ischemic heart disease was found in 34% of cases (p <0.01).
Conclusion: In our study, hyperuricemia in type 2 diabetes is common in female patients, especially with hypertension, dyslipidemia, and renal failure. Other factors such as age, obesity, smoking is not associated with hyperuricemia in type 2 diabetics.
Type 2 diabetes accounts for about 90% of diabetes  its incidence is rising sharply, it has become a public health problem. The International Diabetes Federation (IDF) estimates that, globally, the number of diabetic to 382 million in 2013 and expected to increase that number to 592 million in 2035 . Cardiovascular illnesses are the leading cause of death and disability among type 2 diabetes [1,2]. Hyperuricemia is a common Type 2 diabetes at very high cardiovascular risk and increasing the morbidity and mortality rates. Thus, the growing burden of long-term diabetes indicates that prevention is urgently needed, underscoring the need for early identification of modifiable risk factors [3-6].
Objective of the Study
Evaluate the relationship between hyperuricemia and diabetes type 2, and determine its predictive factors in this population.
Patients and Methods
Retrospective study cross including 191 patients with type 2 diabetes hospitalized in Endocrinology CHU Ibn Rushd service of Casablanca in January 2015 to December 2017. Hyperuricemia was defined as a serum uric acid concentration> 70 mg/L (men) and> 60 mg/L (women).
Collection and Analysis of Data:
Patients admitted to the hospital for a day or uric acid assay was done systematically in asymptomatic patients.
Data were collected from medical records of patients with a form of a farm and collected in an Excel table.
Statistical analysis was performed using SPSS Version 22.0.
Anthropometric measurements (weight, height, waist circumference, BMI).
Cardiovascular factors (tobacco, hypertension, dyslipidemia).
Degenerative complications (retinopathy, neuropathy, nephropathy, ischemic heart disease).
Were included in the study all patients with type 2 consultants were excluded patients followed for gout.
The average age of patients was 53.9 years (27-80).
Hyperuricemia was found in 26.5% of patients with a female predominance (76%), an average age of 55.9 years, and an average age of 12.4ans diabetes. The glycemic control was found in 84.6% of cases with mean glycated hemoglobin 8.6%. The Table-1 shows the general characteristics of our patients:
The factors associated with hyperuricemia were hypertension in 86% of patients were (p <0.05), dyslipidemia in 76% of cases (p <0.001) with hypertriglyceridemia in 48.3% of cases (p <0.02) and hypoHDLémie in 28% (p <0.001), renal failure (GFR between 15 and 60ml / min) 47% (p <0.001), it was of moderate type at 35.8% (p <0.01) and severe in 5.1 % (p <0.02). Ischemic heart disease was found in 34% of cases (p <0.01). Age, obesity, smoking, glycemic control, diabetic retinopathy, and diabetic neuropathy and were not significantly associated with hyperuricemia.
Table-2 shows the prevalence of cardiovascular risk factors associated with hyperuricemia.
The hyperuricemia is defined by serum levels of uric acid above the normal reference range (> 5.5 mg per deciliter (mg/dl) for children and greater than 7.2 to 6.0 mg/dl respectively men and adult women). Uric acid is a final enzyme product in the degradation of nucleotide purine. It can trap oxygen free radicals and protect erythrocyte membrane lipid oxidation [3,4]. Some studies have shown that hyperuricemia is a risk factor for CVD in the general population [7-13] and studies on laboratory animals have also shown that a high concentration of uric acid plays a causal role in SM [14,15]. Other studies have also indicated that a high level of uric acid predicts the development of MS . A meta-analysis of nine studies including 20,891 patients with type 2 diabetes found that hyperuricemia is an independent predictor of vascular complications and cardiovascular mortality in patients with T2DM [17-19].
Although studies have shown that hyperuricemia was a risk factor for type 2 diabetes, the association between the two remains controversial [12-14]. Hyperuricemia may also indirectly affect the progression of diabetes [15,16] Its prevalence varies between 16.1% and 36.2% of cases [7,20]. Patients with diabetes have a prevalence of hyperuricemia higher compared to nondiabetic patients [13,21]. In our study, the prevalence of hyperuricemia was 26% of cases. It is strongly correlated with dyslipidemia including hypertriglyceridemia and hypoHDLémie, high blood pressure, which accords with the literature [22-24].
In the Egyptian case-control study conducted on 986 patients and divided into 3 groups. 352 with type 2 diabetes for less than 5 years, 384 patients with type 2 diabetes for more than 5 years, and 250 non-diabetic controls showed that 32% of patients with type 2 diabetes showed hyperuricemia. The increase in serum uric acid was correlated with high blood pressure, in the presence of albuminuria and renal insufficiency.
In our study, hyperuricemia in type 2 diabetes is common in female patients, especially with hypertension, dyslipidemia, and renal failure. Other factors such as age, obesity, smoking is not associated with hyperuricemia in type 2 diabetics. The hyperuricemia is also correlated to a greater prevalence of degenerative complications including diabetic retinopathy and ischemic heart disease.
 Choukem SP, Mengue JA, Doualla MS, Donfack OT, Beyiha G, Luma HN. Hyperuricaemia in patients with type 2 diabetes in a tertiary healthcare centre in sub-Saharan Africa: prevalence and determinants. Trop Doct. 2016 Oct;46(4):216-21. [PMID: 26774111]
 Wang J, Chen RP, Lei L, Song QQ, Zhang RY, Li YB, Yang C, Lin SD, Chen LS, Wang YL, Zhao F, Liang GX, Hu BC, Lin JC, Cai DH. Prevalence and determinants of hyperuricemia in type 2 diabetes mellitus patients with central obesity in Guangdong Province in China. Asia Pac J Clin Nutr. 2013;22(4):590-98. [PMID: 24231020]
 Rao TM, Vanukuri NK. A study on serum uric acid levels in type 2 diabetes mellitus and its association with cardiovascular risk factors. IAIM. 2016;3(12):148-55.
 Tripathy JP, Thakur JS, Jeet G, Chawla S, Jain S, Pal A, Prasad R. Burden and risk factors of dyslipidemia-results from a STEPS survey in Punjab India. Diabetes Metab Syndr. 2017 Nov;11 Suppl 1:S21-S27. [PMID: 27595388]
 Mundhe SA, Dinkar RM. The study of prevalence of hyperuricemia and MetS in T2DMmellitus. Int J Adv Med. 2016;3(2):241-49.
 Ishizaka N, Ishizaka Y, Toda E, Nagai R, Yamakado M. Association between serum uric acid, metabolic syndrome, and carotid atherosclerosis in Japanese individuals. Arterioscler Thromb Vasc Biol. 2005 May;25(5):1038-44. [PMID: 15746438]
 Krishnan E, Pandya BJ, Chung L, Hariri A, Dabbous O. Hyperuricemia in young adults and risk of insulin resistance, prediabetes, and diabetes: a 15-year follow-up study. Am J Epidemiol. 2012 Jul 15;176(2):108-16. [PMID: 22753829]
 Wang M, Zhao D, Wang W, Liu J, Liu J, Liu S. A prospective study on relationship between blood uric acid levels, insulin sensitivity and insulin resistance. Zhonghua Nei Ke Za Zhi. 2007 Oct;46(10):824-26. [Article in Chinese] [PMID: 18218233]
 Kodama S, Saito K, Yachi Y, Asumi M, Sugawara A, Totsuka K, Saito A, Sone H. Association between serum uric acid and development of type 2 diabetes. Diabetes Care. 2009 Sep;32(9):1737-42. [PMID: 19549729]
 Sudhindra RM, Bino JS. A study of Serum uric acid in diabetes mellitus and pre-diabetes in a south Indian tertiary care hospital. Nitte University Journal of Health Science. 2012;2(2):18-23.
 Li L, Yang C, Zhao Y, Zeng X, Liu F, Fu P. Is hyperuricemia an independent risk factor for new-onset chronic kidney disease?: A systematic review and meta-analysis based on observational cohort studies. BMC Nephrol. 2014 Jul 27;15:122. [PMID: 25064611]
 Lv Q, Meng XF, He FF, Chen S, Su H, Xiong J, Gao P, Tian XJ, Liu JS, Zhu ZH, Huang K, Zhang C. High serum uric acid and increased risk of type 2 diabetes: a systemic review and meta-analysis of prospective cohort studies. PLoS One. 2013;8(2):e56864. [PMID: 23437258]
 Ficociello LH, Rosolowsky ET, Niewczas MA, Maselli NJ, Weinberg JM, Aschengrau A, Eckfeldt JH, Stanton RC, Galecki AT, Doria A, Warram JH, Krolewski AS. High-normal serum uric acid increases risk of early progressive renal function loss in type 1 diabetes: results of a 6-year follow-up. Diabetes Care. 2010 Jun;33(6):1337-43. [PMID: 20332356]
 Rodrigues TC, Maahs DM, Johnson RJ, Jalal DI, Kinney GL, Rivard C, Rewers M, Snell-Bergeon JK. Serum uric acid predicts progression of subclinical coronary atherosclerosis in individuals without renal disease. iabetes Care. 2010 Nov;33(11):2471-73. [PMID: 20798338]
 Chiou WK, Wang MH, Huang DH, Chiu HT, Lee YJ, Lin JD. The relationship between serum uric acid level and metabolic syndrome: differences by sex and age in Taiwanese. J Epidemiol. 2010;20(3):219-24. [PMID: 20308795]
 Zoppini G, Targher G, Bonora E. The role of serum uric acid in cardiovascular disease in type 2 diabetic and non-diabetic subjects: a narrative review. J Endocrinol Invest. 2011 Dec;34(11):881-86. [PMID: 22322536]
 Jalal DI, Rivard CJ, Johnson RJ, Maahs DM, McFann K, Rewers M, Snell-Bergeon JK. Serum uric acid levels predict the development of albuminuria over 6 years in patients with type 1 diabetes: findings from the Coronary Artery Calcification in Type 1 Diabetes study. Nephrol Dial Transplant. 2010 Jun;25(6):1865-69. [PMID: 20064950]
 Hovind P, Rossing P, Tarnow L, Johnson RJ, Parving HH. Serum uric acid as a predictor for development of diabetic nephropathy in type 1 diabetes: an inception cohort study. Diabetes. 2009 Jul;58(7):1668-71. [PMID: 19411615]
 Bjornstad P, Roncal C, Milagres T, Pyle L, Lanaspa MA, Bishop FK, Snell-Bergeon JK, Johnson RJ, Wadwa RP, Maahs DM. Hyperfiltration and uricosuria in adolescents with type 1 diabetes. Pediatr Nephrol. 2016 May;31(5):787-93. [PMID: 26701836]
 Fouad M, Fathy H, Zidan A. Serum uric acid and its association with hypertension, early nephropathy and chronic kidney disease in type 2 diabetic patients. J Bras Nefrol. 2016 Dec;38(4):403-10. [PMID: 28001185]
 Lytvyn Y, Škrtić M, Yang GK, Yip PM, Perkins BA, Cherney DZ. Glycosuria-mediated urinary uric acid excretion in patients with uncomplicated type 1 diabetes mellitus. Am J Physiol Renal Physiol. 2015 Jan 15;308(2):F77-83. [PMID: 25377916]